Tanoue K - Search Results

1

Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells.

Motoshima T, Komohara Y, Horlad H, Takeuchi A, Maeda Y, Tanoue K, Kawano Y, Harada M, Takeya M, Eto M. Motoshima T, et al. Among authors: tanoue k. Oncol Rep. 2015 Jun;33(6):2947-53. doi: 10.3892/or.2015.3893. Epub 2015 Apr 2. Oncol Rep. 2015. PMID: 25845968

2

Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report.

Wada Y, Uchiba M, Kawano Y, Kai N, Takahashi W, Honda J, Tanoue K, Maeda Y, Murakami Y, Eto M, Imamura T. Wada Y, et al. Among authors: tanoue k. J Med Case Rep. 2012 Nov 6;6:378. doi: 10.1186/1752-1947-6-378. J Med Case Rep. 2012. PMID: 23130841 Free PMC article.

3

CXCL10 and CCL2 mRNA expression in monocytes is inversely correlated with the HLA-DR lower fraction of monocytes in patients with renal cell carcinoma.

Motoshima T, Komohara Y, Horlad H, Tsukamoto H, Fujita M, Saito Y, Tanoue K, Kasejima Y, Sugiyama Y, Kawano Y, Nishimura Y, Takeya M, Eto M. Motoshima T, et al. Among authors: tanoue k. Oncol Lett. 2016 Mar;11(3):1911-1916. doi: 10.3892/ol.2016.4132. Epub 2016 Jan 20. Oncol Lett. 2016. PMID: 26998099 Free PMC article.

4

Complete remission with tyrosine kinase inhibitors in renal cell carcinoma.

Wada Y, Tanoue K, Takahashi W, Eto M. Wada Y, et al. Among authors: tanoue k. Transl Androl Urol. 2012 Dec;1(4):204-6. doi: 10.3978/j.issn.2223-4683.2012.05.04. Transl Androl Urol. 2012. PMID: 26816712 Free PMC article. No abstract available.

5

Advanced prostate cancer discovered with cancerous peritonitis: Case report.

Kurahashi R, Fukushima Y, Motoshima T, Murakami Y, Yatsuda J, Yamaguchi T, Tanoue K, Sugiyama Y, Nishi K, Kamba T. Kurahashi R, et al. Among authors: tanoue k. Urol Case Rep. 2018 Oct 22;22:31-33. doi: 10.1016/j.eucr.2018.10.010. eCollection 2019 Jan. Urol Case Rep. 2018. PMID: 30510901 Free PMC article. No abstract available.

6

[The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort].

Kanno T, Inoue T, Ito K, Kono Y, Kawanishi H, Okumura K, Yamada H, Kubota M, Kawakita M, Fujii M, Terada N, Kamoto T, Shimizu Y, Ito N, Tanoue K, Kamba T, Kobori G, Moroi S, Hamada A, Masui K, Shichiri Y, Shibasaki N, Akao T, Sawada A, Saito R, Kobayashi T, Ogawa O. Kanno T, et al. Among authors: tanoue k. Hinyokika Kiyo. 2019 Nov;65(11):439-444. doi: 10.14989/ActaUrolJap_65_11_439. Hinyokika Kiyo. 2019. PMID: 31902175 Free article. Japanese.

7

[Case of giant primary juvenile hepatic cancer with thrombocytosis].

Furukawa Y, Tanoue K, Yamaguchi T, Katayama T, Maezawa H. Furukawa Y, et al. Among authors: tanoue k. Naika. 1970 Oct;26(4):745-9. Naika. 1970. PMID: 5470881 Japanese. No abstract available.

8

Low-contrast dose protection protocol for diagnostic computed tomography in patients at high-risk for contrast-induced nephropathy.

Kidoh M, Nakaura T, Awai K, Matsunaga Y, Tanoue K, Harada K, Uemura S, Yamashita Y. Kidoh M, et al. Among authors: tanoue k. J Comput Assist Tomogr. 2013 Mar-Apr;37(2):289-96. doi: 10.1097/RCT.0b013e318279bd20. J Comput Assist Tomogr. 2013. PMID: 23493222

9

[Experimental studies on the physiopathology of neurogenic bladder due to spinal cord injury, with special reference to the effect of drugs on the smooth muscle of the bladder in the acute stage].

Tanoue K. Tanoue K. Hinyokika Kiyo. 1969 May;15(5):321-36. Hinyokika Kiyo. 1969. PMID: 5816784 Free article. Japanese. No abstract available.

10

Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.

Yamaguchi K, Ito M, Isobe T, Koreishi S, Taguchi R, Uehara K, Ueno S, Imajima T, Kitazono T, Tsuchihashi K, Ohmura H, Yoshihiro T, Tanoue K, Nishiyori S, Iwama E, Maeda T, Akashi K, Baba E. Yamaguchi K, et al. Among authors: tanoue k. JCO Precis Oncol. 2024 May;8:e2300681. doi: 10.1200/PO.23.00681. JCO Precis Oncol. 2024. PMID: 38748981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page